Compare LSTA & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LSTA | TPCS |
|---|---|---|
| Founded | 1980 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.9M | 45.1M |
| IPO Year | 2000 | 2008 |
| Metric | LSTA | TPCS |
|---|---|---|
| Price | $1.55 | $5.10 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 265.5K | 21.0K |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.42 | ★ 41.38 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,283,868.00 | $31,644,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 56.90 | N/A |
| 52 Week Low | $0.99 | $2.88 |
| 52 Week High | $5.07 | $6.31 |
| Indicator | LSTA | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 43.03 | 41.81 |
| Support Level | $1.35 | $5.12 |
| Resistance Level | $2.06 | $5.69 |
| Average True Range (ATR) | 0.18 | 0.14 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 1.72 | 11.04 |
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
Techprecision Corp manufactures precision, large-scale fabricated and machined metal structural components and systems. The company provides end-to-end services, transforming raw materials into precision finished products through custom fabrication, precision machining, assembly, integration, inspection, non-destructive evaluation, and testing. It manufactures products in accordance with customers' drawings and specifications while complying with applicable national and international industry codes and standards. Its segments are: Ranor, which generates the majority of revenue, and Stadco, both focused on the manufacture and assembly of components mainly for defense and other precision industrial customers.